MedTrace Logo

Kombucha Tea for Improving Defecation in Patients With Schizophrenia- a Randomized Controlled Study

NCT06502509 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2024-07-16

No results posted yet for this study

Summary

Patients with schizophrenia frequently have difficulties in bowel habits due to medical adverse effects and unhealthy lifestyle, and the use of various interventions to ameliorate the problems have been noted in clinical setting. Probiotics including Kombucha tea have been proved to modulate the human gut microbiota which may help to improve the stool passage, and have been attracting the public attention across the world. However, little is known among the patients with schizophrenia. In the present study, the research team intends to evaluate effectiveness of Kombucha tea when used in the clinical settings.

Conditions

Interventions

DIETARY_SUPPLEMENT

Commercial Kombucha tea (Brand name E-Ben Organic Kombucha Lemon)

Commercial lemon kombucha tea (Brand:E-Ben Organic Kombucha Lemon), which will be given to participants in opaque bottles for 8 weeks.

DIETARY_SUPPLEMENT

Lemon tea

Diluted lemon juice with the same pH as the commercial kombucha tea as placebo, which will be given to participants in opaque bottles for 8 weeks.

Sponsors & Collaborators

  • CHYUAN JEOU RONG ENTERPRISE CO., LTD

    collaborator UNKNOWN

  • TsaoTun Psychiatric Center, Department of Health, Taiwan

    lead OTHER

Principal Investigators

  • An-Yu Hong · Tsao-Tun Psychiatric Center, Ministry of Health and Welfare

  • Ying-Jyun Shih · Tsao-Tun Psychiatric Center, Ministry of Health and Welfare

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-11
Primary Completion
2024-06-03
Completion
2024-07-08

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06502509 on ClinicalTrials.gov